Evaluation of Specialty Pharmacy in an Integrated Health-System
|
|
- Lewis Ross
- 5 years ago
- Views:
Transcription
1 Evaluation of Specialty Pharmacy in an Integrated Health-System Emma Chermely, PharmD, BCACP Alyssa McCann, PharmD, BCACP *The presenters have no conflicts of interest to disclose.
2 Objectives Introduce the background of specialty pharmacy Evaluate UC Health s Specialty Pharmacy patient population and services Describe the impact a specialty pharmacy can have within a health-system Describe the various role for pharmacy technicians within a specialty pharmacy*. * Technician Learning objective
3 What is a specialty pharmacy? State-licensed pharmacies that solely or largely provide only medications for serious complex health conditions Connect severely ill patients with disease specific high cost, high touch medications Provide patient care services Support patients through reimbursement challenges Excellent services drive adherence and ensure appropriate medication use The National Association of Specialty Pharmacy. NASP Definitions of Specialty Pharmacy and Specialty Medications (Feb 2016). (accessed 25 Mar 2018). M Goldenhorn, R Smith, PT Rocafort. Understanding the high-touch model. Getting acquainted with specialty pharmacy (Mar 2014). ACPE CE. (accessed 25 Mar 2018).
4 What are specialty medications? Medications that require intensive patient management May require special handling, storage and/or administration May be administered orally, subcutaneously, or intravenously May cost up to $750,000 per year Require comprehensive patient care, clinical management, and product support services The National Association of Specialty Pharmacy. NASP Definitions of Specialty Pharmacy and Specialty Medications (Feb 2016). (accessed 25 Mar 2018). M Goldenhorn, R Smith, PT Rocafort. Understanding the high-touch model. Getting acquainted with specialty pharmacy (Mar 2014). ACPE CE. (accessed 25 Mar 2018).
5 Impact of Specialty Medications AJPB Top 5 Medications Humira Harvoni Enbrel Rituxan Remicade AJHP Top 5 Medications Humira Lantus Harvoni Enbrel Remicade Spending on specialty medications doubled from 2010 to 2015 Specialty medications contributed 70% to overall growth of drug expenditures Toich L. Top 5 highest-selling drugs of AJPB (Aug 2017) (accessed 25 Mar 2018) Shumock et al. National trends in prescription drug expenditures and projections for AJHP (May 2017). (accessed 2018 Mar 25) IMS Institute for Healthcare Informatics. Medicines use and spending in the U.S. A review of 2015 and outlook to 2020 (April 2016). www. imshealth.com/en/thoughtleadership/quintilesims-institute/reports/ medicines-use-and-spending-in-the-us-a-review-of-2015-and-outlook-to-2020 (accessed 2018 Mar 25).
6 Growth of Specialty Pharmacies Figure 1. Pharmacy Locations with Specialty Pharmacy Accreditation by Corporate Ownership 2015 vs 2016 CAGR: compound annual growth rate Figure 2. Pharmacy Industry Prescription Revenue ($ Billions) Steiber, Dan. Proving value in specialty pharmacy practice: a new yardstick. AJPB (Nov/Dec 2017). (accessed 25 Mar 2018).
7 Health-System Specialty Models University of Utah Health Care Implemented in 2014 Added 8 technician FTE and 1 pharmacist FTE Goals: 1. Develop centralized prior authorization (PA) process 2. Develop a call center to provide specialty pharmacy services 3. Utilize Electronic Medical Record (EMR) documentation Program Results 137% increase in specialty pharmacy revenue in fiscal year 2015 Average PA approval time of 3 business days Excluded cases involving denials or appeals Rim M. Am J Health Syst Pharm Jun 1; 73(11):831-8.
8 Health-System Specialty Models Vanderbilt Specialty Pharmacy 20 specialty clinics 24 clinical pharmacists and 20 technicians Specialty pharmacists and technicians work from clinic Services are tailored to individual clinic Basic Services Patient counseling Benefits Investigating/Prior Authorization Financial counseling Refill reminder calls 24-hour on-call pharmacist Free shipping Customizable Services Assist in medication selection Lab monitoring Collaborative Practice Agreement Adherence monitoring REMS program management Independent pharmacist clinic visits Bagwell A. J Manag Care Spec Pharm, 2017 Aug; 23(8):
9 UC Health Specialty Pharmacy Opened in October 2016 Obtained URAC Accreditation in July 2017 Staffing: 4.5 pharmacists and 2 technicians Service lines covered Solid Organ Transplant Oncology/Hematology Infectious Diseases Gastroenterology Neurology (Multiple Sclerosis) Cardiology
10 UC Health Specialty Pharmacy Workflow Technician Technician xx Benefits Investigation xx Initiate Prior Authorization xx Approved Document Document Document Uninsured xxmedication Access Referral Z Insured xx Denied High Copay Z Dispense or Transfer Technician Technician Document
11 UC Health Specialty Pharmacy Workflow Initial Assessment Refill Call Routine Assessment
12 UC Health Specialty Pharmacy TherigySTM utilized as patient management system Not integrated with Epic Cloud-based product that contains: Patient demographics Therapeutic category Medication Prior authorization information Various activities Medication refills, clinical assessments, clinical interventions
13 Patients UC Health Specialty Pharmacy Patients HCV HIV Hem/Onc Transplant Other Disease State Total 1,189 Patients
14 Transplant Type Patients by Transplant Type Transplant Service started in October pharmacist Coordinate, fill, and ship all medications for patient Initial and quarterly assessment If > 3 years from transplant, annual assessments Recent study showed improved Proportion of Days Covered (PDC) with specialty pharmacy 88% to 97% (p<0.001) Pancreas Kidney/Pancreas Kidney/Liver Liver Kidney Heart/Kidney Heart Patients
15 Human Immunodeficiency Virus (HIV) Service rapidly expanded in January Active Patients 1.5 Clinical Pharmacists 1 Technician
16 Hepatitis C (HCV) 143 Active Patients 1 Clinical Pharmacist Prior Authorization (PA) turnaround time of 4 business days Month Total Prior Authorizations Prescriptions filled at Specialty January February 32 14
17 Hematology/Oncology 134 Active Patients 16 Hematology 118 Oncology 1 Clinical Pharmacist PA turnaround time of 2 business days Month Total Prior Authorizations Prescriptions filled at Specialty January February 27 14
18 Additional Benefits of an Integrated Specialty Pharmacy Decreased fragmentation Coordinated care within one health-system Utilization of patient s medical record for communication Improved access to medication for patients Increased patient and provider satisfaction
19 UC Health Medication Access Services Operate with 1 Coordinator and 6 Advocates Highly integrated within UC Health Assist patients and providers with Review and Verification of Insurance Coverage Insurance Benefit Selection Medicare Part D and Medicare Extra Help Diagnosis-specific Foundation Assistance Pharmaceutical-specific Co-pay Assistance Pharmaceutical-specific Patient Assistance Programs 30% of specialty patients utilize these services
20 Revenue Number of Patients $180, $160, $140, $120, $100, $80, $60, $40, $20, $- Specialty Pharmacy Revenue from Medication Access Services January February March April May June July August September October November December January Month Number of Patients Revenue
21 Cost Avoidance Number of Patients $250, $200, Specialty Pharmacy Cost Avoidance from Medication Access Services $150, $100, $50, $- January February March April May June July August September October November December January Month 0 Cost Avoidance Number of Patients
22 UC Health Specialty Pharmacy Quality Management Satisfaction surveys conducted quarterly Utilizes a 5 point Likert scale Overall satisfaction of 4.87 and 4.91 for providers and patients Majority of patients received medications via mail Lowest score was affordability of medications 97.3% of patients would recommend UC Health Specialty Pharmacy 91.3% of providers would strongly recommend UC Health Specialty Pharmacy to colleagues
23 UC Health Specialty Pharmacy Growth *Includes data through 1/31/18
24 UC Health Specialty Pharmacy Growth *Includes data through 1/31/18
25 UC Health Specialty Pharmacy Barriers to Care Patient population Limited access to medications Medication cost Pharmacy Benefit Manager (PBM) restrictions Ohio is not an any willing provider state
26 UC Health Specialty Pharmacy Future Directions Increase staffing Individualized roles for pharmacy technicians Expansion to more specialty clinics Increase access to medications Incorporation of the 4 P s Patient Providers Pharma Payers
27 Active Learning #1 According to AJPB and AJHP, what was the top selling specialty medication in 2016? A. Imbruvica B. Harvoni C. Prograf D. Humira
28 Active Learning #2 What are the 4 P s of Specialty Pharmacy? A. Patient, Product, Providers, Pharmacy B. Patient, Product, Pharma, Payers C. Patient, Providers, Pharma, Payers D. Patient, Providers, Pharmacy, Payers
29 Evaluation of Specialty Pharmacy in an Integrated Health-System Emma Chermely, PharmD, BCACP Alyssa McCann, PharmD, BCACP *The presenters have no conflicts of interest to disclose.
Justifying New Oncology Pharmacist Positions
Faculty Disclosures Justifying New Oncology Pharmacist Positions I will not be discussing off-label uses of any medications I am on the speaker s bureau for Millenium Pharmaceuticals and am a paid consultant
More informationThe Un-Special World of Specialty Medications
The Un-Special World of Specialty Medications Manpreet Chahal, PharmD, PhD Oncology Pharmacist, Medical Oncology Associates, Spokane WA Adjunct Clinical Instructor, WSU College of Pharmacy mschahal@wsu.edu
More informationWalgreens Enterprise Specialty Pharmacy
Walgreens Enterprise Specialty Pharmacy Chris Creamer Senior Director, Specialty Operations August 17, 2017 Member of Walgreens Boots Alliance Core objectives for today at a glance Discuss the Key Market
More informationPanel Discussion: Orals Adherence & Challenges Friday, April 28 th, 2017
Panel Discussion: Orals Adherence & Challenges Friday, April 28 th, 2017 1 2017 Community Oncology Alliance Panel Discussion: Orals Adherence & Challenges Ray Bailey, RPh, Director of Pharmacy Florida
More informationCommunity-Based Point-of-Care Testing: From Innovative Care Model to Common Practice
Community-Based Point-of-Care Testing: From Innovative Care Model to Common Practice Donald G. Klepser, PhD, MBA Associate Professor University of Nebraska Medical Center Brian Bobby Rite Aid Vice President,
More informationCost-Effective Process to Improve Drug Adherence for Medicare 5-Star
Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star HEALTH ALLIANCE PLAN Presented by Vanita K. Pindolia, Pharm.D. VP, Ambulatory Clinical Pharmacy Programs_PCM Medicare 5-Star Rating
More information9/25/15. Pharmacy Quality Measures: Financial Support. Learning Objectives. Speaker Disclosure. Access to Preferred Networks and Clinical Performance
Pharmacy Quality Measures: Action Steps for Improvement Financial Support Financial support was provided for this activity through an unrestricted grant from Health Mart Systems, Inc. Christine Jacobson
More informationRole of the Clinical Pharmacist in Primary Care
Role of the Clinical Pharmacist in Primary Care Amy Kramer, Pharm.D., Manager Clinical Pharmacy Services Kaiser Permanente Holly Miller, Pharm.D., BCACP, Primary Care Clinical Pharmacist Kaiser Permanente
More informationNavigating The Prior Authorization Approval Process. Kristin Webb, RPCA University at Buffalo
Navigating The Prior Authorization Approval Process Kristin Webb, RPCA University at Buffalo Disclosures DISCLOSURES Commercial Entity Relevance Role K. Webb Abbvie Merck, AbbVie, Tobira, Gilead Honorarium
More informationNavigating The Prior Authorization Approval Process
Navigating The Prior Authorization Approval Process Kristin Webb, RPCA University at Buffalo Disclosures DISCLOSURES Commercial Entity Relevance Role K. Webb Abbvie Merck, AbbVie, Tobira, Gilead Honorarium
More informationHow one pharmacy is bringing specialty drugs to an independent community pharmacy setting
, S E Y t a h t it s How one pharmacy is bringing specialty drugs to an independent community pharmacy setting by LeAnn W. O Neill, PharmD; Vanessa K. Hoffman, PharmD, CGP; Barry S. Bryant, RPh; and John
More informationPopulation Health Management Design: Optimizing the Outcomes for Special Populations 21th Annual ASHP Conference for Pharmacy Leaders
Learning objectives Define population health and its impact on pharmacy leaders. Population Health Management Design: Optimizing the Outcomes for Special Populations Meghan D. Swarthout, PharmD, MBA, BCPS
More informationPre-exposure Prophylaxis for HIV Prevention
Mountain West AIDS Education and Training Center Pre-exposure Prophylaxis for HIV Prevention Cost and Access: Tips from the Field Joanne Stekler, MD MPH October 12, 2017 This presentation is intended for
More informationComprehensive support for your patients on MYALEPT
Comprehensive support for your patients on MYALEPT Insurance and financial assistance options (see page 3) Fulfillment support (see page 6) Co-pay assistance a,b (see page 4) Your patient Injection training
More informationTips for Evolving Medicaid Pharmacy Benefits Management (PBM) Programs. June 5, 2015
Tips for Evolving Medicaid Pharmacy Benefits Management (PBM) Programs 1 June 5, 2015 Introductions Mark Steck Pharm.D Independent Consultant, MAXIMUS John J.P. Crouse Vice President, MAXIMUS Market Lead
More informationPharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica
Pharmacy Trends and Management Opportunities Kerry Bendel, R.Ph. Director of Pharmacy Medica September 14, 20 1 Agenda Pharmacy Trend Experience Trend Drivers and Management Opportunities Call to Action
More informationTHE GROWTH OF SPECIALTY PHARMACY
UnitedHealth Center for Health Reform & Modernization THE GROWTH OF SPECIALTY PHARMACY Current trends and future opportunities Issue Brief April 2014 Summary Innovative specialty drugs are providing important
More information2015 Annual Convention
2015 Annual Convention Date: Tuesday, October 13, 2015 Time: 8:00 am 9:30 am Location: Gaylord National Harbor Resort and Convention Center, National Harbor 2 Title: Activity Type: Speaker: Benefit from
More informationMagellan Rx. A smarter approach to pharmacy benefits management
Magellan Rx A smarter approach to pharmacy benefits management Presented by: Cheri Caruso, VP of Sales, Magellan Rx Management Bryce Canfield, VP, Client Development, GoodRx A unique vision of care We
More informationSpecialty Drugs in Workers Compensation
Specialty Drugs in Workers Compensation A GUIDE FOR CLAIMS HANDLERS Specialty Drugs Specialty drugs have been developed in response to demand for specialized medications for complex medical conditions.
More informationPHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS
PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS For Producer Audience Only - Please Do Not Distribute Regence has selected Prime Therapeutics as the Pharmacy benefits manager for its health plans.
More informationIOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax
IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA 50315 (515) 974-3131 Fax 1-866-626-0216 Brett Faine, Pharm.D. Larry Ambroson, R.Ph. Casey Clor, M.D. Mark Graber, M.D.,
More informationDigital Technologies: The Solutions to Poor Medication Adherence?
Digital Technologies: The Solutions to Poor Medication Adherence? Jeffrey Mesaros, PharmD Annual Meeting & Exposition Seattle, Washington March 22-25 1 Disclosures The views and opinions expressed in the
More informationMArch The 2014 Drug Trend Report Highlights
MArch 2015 The 2014 Drug Report Highlights Highest Increase in U.S. Drug Spend Over Past Decade In 2014, the pharmacy landscape underwent a seismic change, and the budgetary impact to healthcare payers
More informationPrescription Benefit Management. Eric Cannon, PharmD, FAMCP
Prescription Benefit Management Eric Cannon, PharmD, FAMCP Agenda Drugs as a Share of Health Spending Top Drugs of 2016 Management Interventions and Strategies Specialty Pharmacy, Generics and Biologics
More informationMary Ann Hodorowicz RDN, MBA, CDE, CEC (Certified
Mary Ann Hodorowicz RDN, MBA, CDE, CEC (Certified Endocrinology Coder) Mary Ann Hodorowicz, RDN, MBA, CDE, CEC, is a licensed registered dietitian and certified diabetes educator and earned her MBA with
More informationUtilization of Telemedicine to Treat Hepatitis C Virus Infection at a Medication Assisted Treatment Program
Utilization of Telemedicine to Treat Hepatitis C Virus Infection at a Medication Assisted Treatment Program Collaborative Effort Between State University of New York - Buffalo Centers for Disease Control
More informationOncology Pharmacy Navigator: A Novel Model for Medication Management
Oncology Pharmacy Navigator: A Novel Model for Medication Management Kelly Rice, Pharm.D. Oncology Pharmacy Navigator Legacy Cancer Institute Portland, Oregon Objectives Understand the role of an oncology
More informationPositive Living Conference
Positive Living Conference Ft. Walton Beach, Thomas Liberti Chief, Bureau of HIV/AIDS Department of Health March 11, 2011 Tallahassee, 1 The Epidemic in, 2010 60% White Population: 18.8 million (4 th 16%
More information16 th Annual IHA Stakeholders Meeting Session 2C
16 th Annual IHA Stakeholders Meeting Session 2C September 19, 2017 Hilton Los Angeles Airport Thank you to our Content Partner: Medication Adherence AppleCare Pharmacy Programs Confidential and proprietary.
More informationMoving the Needle: How Are We Doing with Patient Adherence to Drug Therapy?
Moving the Needle: How Are We Doing with Patient Adherence to Drug Therapy? 2018 Patient Adherence Influence Report By Mike Occhipinti and Linda Morini 2018 Syneos Health. All rights reserved. MOVING THE
More informationPharmacy Partnership to Improve Patient Outcomes
Pharmacy Partnership to Improve Patient Outcomes Minnesota Rural Health Conference Session 2B Ryan M. Harden, MD MS Kendra Metz, Pharm D Sarah Nelson, MD June 25, 2018 Involved Partners Involved Partners
More informationRethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands
Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Objectives Identify patient barriers to medication adherence. Describe the clinical and economic impact of
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Valcyte) Reference Number: ERX.NPA.33 Effective Date: 06.01.15 Last Review Date: 08.17 Line of Business: Commercial [Prescription Drug Plan] Revision Log See Important Reminder at the
More informationHelpful Resources for people with Diabetes
Helpful Resources for people with Diabetes Help with Diabetes tablets and insulin The goal of the program is to help eligible uninsured and underinsured patients of all ages receive needed prescription
More informationAzPA Southwestern Clinical Seminar. JW Marriott Starr Pass Blvd., Tucson, AZ
AzPA Southwestern Clinical Seminar JW Marriott 3800 Starr Pass Blvd., Tucson, AZ Time Program CE 8:00-9:30am Emerging Infectious Disease Outbreaks in Arizona, the U.S., and the World Lydia Plante, MSPH,
More informationContinuing Education. An integral member of the healthcare team Utilize creative technology Intentional in marketing
Upon successful completion of this article, the pharmacist (or pharmacy technician) should be able to: Describe the key points of the clinical community pharmacist Define the prevalence of the major chronic
More informationMarket Distortions from the 340B Drug Pricing Program
Market Distortions from the 340B Drug Pricing Program Adam J. Fein, Ph.D. www.drugchannels.net @DrugChannels The opinions and views expressed in this presentation are those of the author and may not reflect
More informationASCO s Quality Training Program
ASCO s Quality Training Program Project Title: Improving oral chemotherapy fulfillment processes and implementation of a pharmacistmanaged oral chemotherapy follow-up program Presenter s Name: Sonja Jacobsen,
More informationAre Specialty Pharmacy Drugs Worth the Cost? How Companies Can Make Them More Affordable.
Are Specialty Pharmacy Drugs Worth the Cost? How Companies Can Make Them More Affordable. BACKGROUND Your Host: Eric Bricker, MD Co-Founder & Chief Medical Officer - Compass Professional Health Services
More informationVaccine Starter Kit Program FAQs
Vaccine Starter Kit Program FAQs Program How does this program help Health Mart pharmacies provide vaccines for their customers? McKesson has designed a comprehensive program specifically for Health Mart
More informationJefferies Healthcare Conference. June 2016
Jefferies Healthcare Conference June 2016 Today s Speakers John Figueroa Chief Executive Officer Vic Breed Chief Financial Officer Joined Genoa in July 2014 Previously served the dual roles of CEO of Apria
More information37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE
37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
More informationSpecialty pharmacy is one of the fastest growing areas of
formulary Management Best Practices in Specialty Pharmacy Management Courtney J. Patterson, PharmD, BCOP ABSTRACT BACKGROUND: Specialty pharmacy is a growing area of research, utilization, and cost. Because
More informationPharmacotherapy selection system supports shared clinician-patient decision-making in diabetes treatment
FOR IMMEDIATE RELEASE Pharmacotherapy selection system supports shared clinician-patient decision-making in diabetes treatment Electronic health record-based comparative display of pharmaceutical options
More informationSFDPH Responds to Hepatitis C: Strategic Directions for and Beyond
SFDPH Responds to Hepatitis C: Strategic Directions for 2015-2016 and Beyond Presented by: Kelly Eagen, MD Physician Specialist Tom Waddell Urban Health San Francisco Health Network Katie Burk, MPH Viral
More informationSpecialty conditions overview
Specialty conditions overview Prevalence and cost Click on the vials to learn more about these specialty conditions. 1. Approximate annual AWP cost per patient of top utilized drugs for UHC calendar year
More informationAdult Immunization Highlights from the 48th National Immunization Conference
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Adult Immunization Highlights from the 48th National Immunization Conference Amy Parker Fiebelkorn,
More informationColorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center
Colorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center Kaela Momtselidze Health Systems Manager Primary Care Systems American Cancer Society Sheri Frank Director of Corporate
More information3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:
Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Addolorata
More informationInnovative Opportunities for Pharmacists in the Evolving World of Healthcare
Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Assistant Clinical
More information2016 Pharmacist Re-Licensure Survey Instrument
1. Sex a. Male b. Female 2016 Pharmacist Re-Licensure Survey Instrument 2. Ethnicity: Are you Hispanic or Latino? a. Yes b. No 3. Race (Check all that apply.) a. American Indian or Alaska Native b. Black
More informationThese reports were prepared pursuant to directive contained in Section 10 of Senate File 2425 which is listed below:
CHESTER J. CULVER, GOVERNOR PATTY JUDGE, LT. GOVERNOR DEPARTMENT OF HUMAN SERVICES EUGENE I. GESSOW, DIRECTOR January 15, 2009 Michael Marshall Secretary of Senate State Capitol LOCAL Mark Brandsgard Chief
More informationGetting started with Prime
Getting started with Prime How does a pharmacy plan work? When you visit your doctor, he or she may prescribe medicine for you. Here's how the plan works: Take your prescription and member ID card to the
More informationIMPACT OF DRUG REBATES ON YOUR PARTICIPANTS AND YOUR PLAN RISK PROFILE Indiana Health and Wellness Summit
IMPACT OF DRUG REBATES ON YOUR PARTICIPANTS AND YOUR PLAN RISK PROFILE 2018 Indiana Health and Wellness Summit National Diabetes Volunteer Leadership Council Who We Are Patient advocacy organization committed
More informationUsing Decision Support to Promote Value Based Prescribing
Using Decision Support to Promote Value Based Prescribing Session 218, February 14, 2019 Adam Szerencsy, DO Medical Director, Ambulatory Informatics NYU Langone Health 1 Conflict of Interest Adam Szerencsy,
More informationWalgreens (WAG) Analyst: Juan Fabres Fall 2014
Recommendation: Buy Target Price August 31, 2016: $77.57 1. Reasons for the Recommendation With the acquisition of Alliance Boots in Europe, Walgreens will be the first US pharmacy to operate retail stores
More informationUp to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data).
HIV Background, new developments, key strategies Drug Class Insight INTRODUCTION Human Immunodeficiency Virus (HIV) is the virus that can lead to Acquired Immunodeficiency Syndrome, or AIDS. No safe and
More informationTelemedicine: Connecting Behavioral Health and Medical Care
Telemedicine: Connecting Behavioral Health and Medical Care Lawrence S. Brown, Jr., MD, MPH, FASAM CEO, START Treatment & Recovery Centers Clinical Associate Professor of Medicine and Health Care and Policy
More informationHow Mail-Servi. Prepared for
How Mail-Servi ice Pharmacies Will Save $46.6 Billion Over the Next Decade and the Cost of Proposed Restrictions Prepared for February 2012 Table of Contents I. Executive Summary... 3 Major Findings on
More informationACIP Recommendations for Adult Pneumococcal Immunization: Helping Pharmacists Assess, Recommend, Administer or Refer. Interim Outcomes Report
ACIP Recommendations for Adult Pneumococcal Immunization: Helping Pharmacists Assess, Recommend, Administer or Refer Grant ID: 29025501 Interim Outcomes Report https://www.powerpak.com/course/preamble/114079
More informationMedication Therapy Management: Improving Health and Saving Money
Medication Therapy Management: Improving Health and Saving Money Ed Staffa, RPh Vice President, Pharmacy Mirixa Corporation estaffa@mirixa.com July 23, 2008 MTM At A Glance The U.S. health care system
More informationTexas Vendor Drug Program Specialty Drug List Process. February 2019
Texas Vendor Drug Program Specialty Drug List Process February 2019 Table of Contents Table of Contents...1 1 About the Specialty Drug List...2 1.1 Information for Pharmacies... 2 1.2 Information for Managed
More informationPrEP Implementation in San Francisco. Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health
PrEP Implementation in San Francisco Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health Why are new prevention strategies needed? New infections
More informationOral Chemotherapy Panel
Panel Disclosures Dr. Chen & Dr. Hudson-DiSalle no relevant financial relationships exist with commercial interests Oral Chemotherapy Panel Dr. Mancini - Speaker s Bureau for Millennium Pharmaceuticals
More informationReducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital
Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital Dawn Waddell, PharmD, BCPS Clinical Pharmacy Manager Lisa Kingdon, PharmD, BCPS Clinical Pharmacy Specialist Dawn Waddell
More informationAn Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder
An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder CONTENTS I. Need for an Alternative Payment Model for Opioid Use Disorder and Addiction... 2 A. Improving Services
More informationCommercial Health Insurance Claims Data. for Studying HIV/AIDS Care. Senior Scientist, Innovus Epidemiology. David D.
Commercial Health Insurance Claims Data for Studying HIV/AIDS Care David D. Dore, PharmD, PhD Senior Scientist, Innovus Epidemiology Adjunct Assistant Professor, Alpert Medical School, Brown University
More informationThe New Role of Cancer Patient Engagement in Value Based Models
Mini Summit XIX: Case Studies in Specialty Medical Homes: How to Design APMs to Support Patients with Serious Health Conditions that Cannot be Managed by a PCP Ray Page, DO PhD The New Role of Cancer Patient
More informationIOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax
IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA 50315 (515) 725-1287 Fax 1-866-626-0216 Bruce Alexander, R.Ph., Pharm.D., BCPP Larry Ambroson, R.Ph. Casey Clor, M.D.
More informationPBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S.
Speaker Brian K. Solow, MD, FAAFP Optum Life Sciences Irvine, CA, USA PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Brian K. Solow, MD, FAAFP Chief Medical Officer, Optum Life Sciences
More informationLeverage Healthcare Technology Applications to Improve Primary Nonadherence.
Leverage Healthcare Technology Applications to Improve Primary Nonadherence. Page 2 Medication adherence starts with assessing a patient s opportunity for having positive outcomes on a specific therapy.
More informationMyriad Genetics Corporate Presentation 06/13/2018
Myriad Genetics Corporate Presentation 06/13/2018 Copyright 2016 2018 Myriad Genetics, Inc., all rights reserved. www.myriad.com. 1 Forward Looking Statements Some of the information presented here today
More informationClinical Policy: Valganciclovir (Valcyte) Reference Number: CP.CPA.116 Effective Date: Last Review Date: Line of Business: Commercial
Clinical Policy: (Valcyte) Reference Number: CP.CPA.116 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important
More informationPrimary Care Pharmacist Integration and Reimbursement Models
Primary Care Pharmacist Integration and Reimbursement Models May 20, 2015 MODERATOR: Marie Smith, PharmD Palmer Professor and Assistant Dean, Practice and Public Policy Partnerships, UConn School of Pharmacy
More informationStrengthening our global leadership in treatment of addiction. Morgan Stanley Global Healthcare Conference September 13 th and 14 th 2018
Strengthening our global leadership in treatment of addiction Morgan Stanley Global Healthcare Conference September 13 th and 14 th 2018 Forward Looking Statements This presentation contains certain statements
More informationBrantley M. Underwood Pharm.D., MBA PGY1 Community Pharmacy Resident Southwestern Oklahoma State University/Walgreen Co
Brantley M. Underwood Pharm.D., MBA PGY1 Community Pharmacy Resident Southwestern Oklahoma State University/Walgreen Co Describe the benefits of using a mobile application as a medication reminder tool
More informationNew patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit:
The Novo Nordisk Diabetes Patient Assistance Program (PAP) provides medication to qualifying applicants at no charge. If the applicant qualifies under the Novo Nordisk Diabetes PAP guidelines, a 120-day
More informationSelf-Insurance 2016 Q2 Update. Presented by Marcy Syman, Human Resources Director
Self-Insurance 2016 Q2 Update Presented by Marcy Syman, Human Resources Director Management Committee 9-12-2016 Dollars in Millions Self-Insured Plan Costs Q2 2016 (Claims, admin fees and stop loss premium)
More informationDoes Variation in the Physical Characteristics of Generic Drugs Affect Patients Experiences?
Does Variation in the Physical Characteristics of Generic Drugs Affect Patients Experiences? Results from a National Survey of Pharmacists and Patients Ameet Sarpatwari, J.D., Ph.D. Instructor in Medicine,
More informationGlobal Rheumatoid Arthritis Market: Trends and Opportunities ( )
Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018) Global Rheumatoid Arthritis Market Report Scope of the report The report titled Global Rheumatoid Arthritis Market: Trends and Opportunities
More informationEnsure access to and compliance with treatment for low-income uninsured Virginia residents living with HIV/AIDS
Public Health/ CHSB Lilibeth Grandas x1211 Sharron Martin x1239 Program Purpose Program Information Ensure access to and compliance with treatment for low-income uninsured Virginia residents living with
More informationWhat CEOs Don t Know about Health System Pharmacy
Pharmacy Executive Forum What CEOs Don t Know about Health System Pharmacy research technology consulting 2 Today s Presenters Rob Lazerow Managing Director The Advisory Board Company lazerowr@advisory.com
More informationCARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:
RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription
More informationPractice Advisory on Drug Coverage Parity across Medical and Pharmacy Benefits
Practice Advisory on Drug Coverage Parity across Medical and Pharmacy Benefits Introduction Oncology medications have historically been administered intravenously in a physician s office, infusion center
More informationTopic: Sovaldi, sofosbuvir Date of Origin: March 14, Committee Approval Date: August 15, 2014 Next Review Date: March 2015
Medication Policy Manual Policy No: dru332 Topic: Sovaldi, sofosbuvir Date of Origin: March 14, 2014 Committee Approval Date: August 15, 2014 Next Review Date: March 2015 Effective Date: October 1, 2014
More informationAddressing Gaps in MS Care. November 6, :00 AM - Noon
Addressing Gaps in MS Care November 6, 2015 11:00 AM - Noon Learning Objectives Understand and confidently communicate the barriers to MS care caused by the shortage of healthcare providers with MS experience,
More informationMaryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center
Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center at the Maritime Institute Pharmacy-Driven Inpatient
More information340B Savings Equals Improved Patient Care
10 th Annual 340B Coalition Winter Conference 340B Savings Equals Improved Patient Care Carol Millage, PharmD Pharmacy Director County of Santa Barbara Public Health February 7, 2014 Statement of Conflicts
More informationTeam-Based Decision Support in Diabetes Outcomes and Costs
Team-Based Decision Support in Diabetes Outcomes and Costs Session 89, 8:30 a.m. February 13, 2019 Gary Ozanich, Ph.D. - College of Informatics, Northern Kentucky University 1 Conflict of Interest Gary
More informationPREVENTATIVE COMMUNITY PHARMACY DIABETES MANAGEMENT PROGRAMS BROOKE HUDSPETH, PHARMD, CDE, MLDE KROGER DIABETES CARE
PREVENTATIVE COMMUNITY PHARMACY DIABETES MANAGEMENT PROGRAMS BROOKE HUDSPETH, PHARMD, CDE, MLDE KROGER DIABETES CARE DISCLOSURE STATEMENT Brooke Hudspeth is employed by The Kroger Co. No other conflicts
More informationThe Sustainability of Irish Pharmaceutical Expenditure. Valerie Walshe Ph.D. Economist
The Sustainability of Irish Pharmaceutical Expenditure Valerie Walshe Ph.D. Economist valerie.walshe@hse.ie February 2015 Content Overview of Irish Health Services Community Drug Prescribing Trends Driving
More informationLetter to the AMGA Board of Directors... 1 Introduction... 3
Table of Contents Letter to the AMGA Board of Directors... 1 Introduction... 3 Section I: Executive Summary Survey at a Glance... 6 Participant Profile... 10 Survey Methodology... 19 How to Use This Report...
More informationApril 2o14. The 2013 Drug Trend Report Highlights
April 2o14 The 2013 Drug Trend Report Highlights Express Scripts Reports Lowest Specialty Drug Trend Since 2007 In 2013, spending on prescription drugs increased 5.4% after several years of slower-paced
More informationZoster Tdap. Marianne Langlois. Tetanus Diptheria (Td) Hepatitis A Hepatitis A & B combo
Marianne Langlois Zoster Tdap Tetanus Diptheria (Td) Hepatitis A Hepatitis A & B combo 2017 National Adult and Influenza Immunization Summit 5/9/2017 1 HFHS CEO Nancy Schlichting met with Merck Vaccine
More information2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan
2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan Plan Details, Programs, and Policies Table of Contents Click on the links below to be taken to that
More informationStatement Of. The National Association of Chain Drug Stores. For. U.S. Senate Finance Committee. Hearing on:
Statement Of The National Association of Chain Drug Stores For U.S. Senate Finance Committee Hearing on: 10:30 a.m. 215 Dirksen Senate Office Building National Association of Chain Drug Stores (NACDS)
More informationHow health plans can improve cancer care: from utilization management to delivery reform
Quality health plans & benefits Healthier living Financial well being Intelligent solutions How health plans can improve cancer care: from utilization management to delivery reform Michael Kolodziej, M.D.,
More informationNavigating Immuno-Oncology Coverage & Reimbursement Issues
Navigating Immuno-Oncology Coverage & Reimbursement Issues Niesha Griffith, RPh, MS, FASHP Administrator of Oncology Pharmacy and Infusion Services at the Arthur G. James Cancer Hospital and Richard J.
More information